The Effect of Dexmedetomidine and Levobupivacaine in an Experimental Ischemia Reperfusion Model
In Vivo · 2024
DOI: 10.21873/invivo.13747 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Turna Halil Ibrahim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia and Reanimation, Health Science University, Hamidiye Etfal, Training, and Research Hospital, Istanbul, Turkey. Hauptthemen laut MEDLINE: Dexmedetomidine, Levobupivacaine, Reperfusion Injury, Disease Models, Animal. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Although it has been reported that different molecules are effective in preventing ischemia-reperfusion (I/R) injury, the most effective treatment is still unknown. MATERIALS AND METHODS: The rats were divided into four groups of eight rats each. Group C: 1 ml intraperitoneal (IP) isotonic + laparotomy + IP 2 ml isotonic +I/R. Group D: 100 μg kg-1/1 ml IP dexmedetomidine + laparotomy + IP 2 ml isotonic +I/R. Group L: 1 ml IP isotonic + laparotomy + IP levobupivacaine (2.5 mg kg-1/2 ml) +I/R. Group DL: 100 μg kg-1/1 ml IP dexmedetomidine + laparotomy + IP levobupivacaine (2.5 mg kg-1/2 ml) +I/R. Brain, heart, lung, and liver tissue samples were collected for histopathological examination. Biochemically, levels of aspartate amino transaminase, alanine amino transaminase, serum glucose, total antioxidant status (TAS), total oxidant status, ischemia modified albumin, and malondialdehyde were measured in blood samples. RESULTS: Group D mean blood TAS levels were found to be statistically significantly higher than those in Group C and Group L (p=0.037, p=0.048 respectively). Group DL oxidative stress index (OSI) value was found to be statistically significantly lower than that of Group C (p=0.010). CONCLUSION: Both dexmedetomidine and levobupivacaine demonstrated protective effects in I/R injury. When used in combination, the effects of these treatments were further enhanced, reaching statistical significance. As our literature review found no studies on the combined use of dexmedetomidine and levobupivacaine in I/R injury, it is anticipated that supporting these results with clinical studies may significantly contribute to clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesia and Reanimation, Health Science University, Hamidiye Etfal, Training, and Research Hospital, Istanbul, Turkey.
- Department of Anesthesia and Reanimation, Health Science University, Hamidiye Etfal, Training, and Research Hospital, Istanbul, Turkey; md.kesici@mynet.com.
- Department of General Surgery, Health Science University, Sultan 2. Abdülhamid Han, Training, and Research Hospital, Istanbul, Turkey.
- Department of Medical Biochemistry, University of Health Sciences, Haydarpasa Numune, Training and Research Hospital, Istanbul, Turkey.
- Department of Pathology, Health Science University, Prof. Dr. Cemil Tascioglu, Training, and Research Hospital, Istanbul, Turkey.
- Department of General Surgery, Health Science University, Prof. Dr. Cemil Tascioglu, Training, and Research Hospital, Istanbul, Turkey.
Zitieren
APA
Ibrahim, T. H., Sevgi, K., Sibel, O., Surhan, C. A., Kaan, K., Kubra, B., Gulcin, K., Metin, G. E., Betul, S. D. N., & Ugur, K. (2024). The Effect of Dexmedetomidine and Levobupivacaine in an Experimental Ischemia Reperfusion Model. In Vivo. https://doi.org/10.21873/invivo.13747
Vancouver
Ibrahim TH, Sevgi K, Sibel O, Surhan CA, Kaan K, Kubra B, et al. The Effect of Dexmedetomidine and Levobupivacaine in an Experimental Ischemia Reperfusion Model. In Vivo. 2024. doi:10.21873/invivo.13747
BibTeX
@article{Ibrahim2024,
author = {Ibrahim, Turna Halil and Sevgi, Kesici and Sibel, Oba and Surhan, Cinar Ayse and Kaan, Karatepe and Kubra, Bozali and Gulcin, Kamali and Metin, Guler Eray and Betul, Sancak Demirci Nur and Ugur, Kesici},
title = {The Effect of Dexmedetomidine and Levobupivacaine in an Experimental Ischemia Reperfusion Model},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13747}
}
EUVIMED